Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Share Purchase Plan

Sep 19, 2018Mark EdwardsNews

19 September 2018

ASX Announcement

Share Purchase Plan

Medical Developments International (ASX: MVP) (Company) advises that it has today successfully completed its Share Purchase Plan (SPP) that has resulted in the issue of 1,868,703 fully paid ordinary shares in the Company at a price of $4.00 per fully paid ordinary share, raising $7.475 million (before costs).

The Company is delighted with the response and has decided not to scale back the applications.

The SPP shares were issued today and trading of the new shares will commence tomorrow. The holding statements will be dispatched to shareholders on 21 September 2018.

 

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter